Stocks Johnson & Johnson

More

  • As the Dow now contains five stocks under $10 (GM, C, BAC, AA, & GE), the Dow Industrials index has come under greater scrutiny on whether it is still a good gauge of the overall market.

  • Gold Bars

    Regarded as a safe investment, gold often shines during turbulent times when increased demand typically drives up prices. For the first time since last March, gold settled above $1,000 an ounce on Friday.  Since its low back in November, when gold was just over $700 an ounce, the bullion has risen 42%. During the same period the S&P 500 has plunged 15%.

  • 090219_WBW_commentary.jpg

    CNBC's Jim Cramer has been critical of Warren Buffett's decision to sell some stocks in the Berkshire Hathaway portfolio, in part because it appears to contradict Buffett's public call to buy U.S. stocks last fall.  But there is another way of looking at it.

  • 090218_cramer_takeson_buffett.jpg

    After warning CNBC viewers not to follow Warren Buffett's recent stock moves, Jim Cramer goes into greater detail today about how Buffett was "selling America" last fall even as he publicly urged investors to buy American stocks.

  • 090217_Jim_Cramer.jpg

    CNBC Mad Money host Jim Cramer doesn't like what he sees in Warren Buffett's latest stock moves for Berkshire Hathaway, and doesn't think ordinary investors should follow the Omaha billionaire's lead this time around.  Buffett has "the luxury of being wrong. The rest of us do not."

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • graphic_word_ofthe_street.jpg

    The Dow slid within striking distance of its bear-market low on Tuesday, despite the fact that President Obama signed the economic stimulus into law. What went wrong?

  • buffett_jnj.jpg

    Instead of asking what Warren Buffett has been buying, we should have been wondering what he's been selling.  Berkshire Hathaway's stock portfolio snapshot for the end of the fourth quarter reveals its holdings in Johnson and Johnson have been slashed by more than half.

  • Looking for a formula for successful stock investing?  RBC Bank's Joseph Keating sums it up in three words:  exceptionally high quality.  Companies in that category, he says, are likeliest to hold onto their dividends. (Part One)

  • Looking for a formula for successful stock investing?  RBC Bank's Joseph Keating sums it up in three words:  exceptionally high quality.  Companies in that category, he says, are likeliest to hold onto their dividends. (Part Two)

  • If you’re looking for trading action look no farther than healthcare. There’s something happening in almost every corner of this sector.

  • We pull apart Barron's attempt to measure Cramer's stock-picking performance.

  • McDonald’s  is trading up after reporting another month of strong same-store sales, a trend that continues despite the current recession and economic turmoil. Its low-priced menu items have evidently remained attractive to consumers. . .

  • Cozad Asset Management's Ron Kiddoo thinks there's an upside to the downside. "I think we're facing a recessionary economy, so we would look at recessionary stocks, such as in health care and consumer staples," he told CNBC. "Perhaps a little bit in the industrial sector..."

  • CEO David Pyott tells investors to think of more than just Botox when his company is mentioned.

  • Intuitive Surgical has rallied more than $20 in the last five sessions since we cited unusual buying of stock and options in the company. The sharp rise has taken place amid persistant takeover rumors involving Johnson & Johnson and the robotic surgery giant.

  • One month into the year, the average dividend yield of the Dow 30 has gone up a bit since 2009 began, but is still down from where it was at the end of November.  See how the 30 companies in the Dow compare.

  • Intuitive Surgical, a California company that makes endoscopic instruments, is running higher along with heavy options activity amid takeover rumors.

  • Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!